Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Dupuis

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Molecular Neurodegeneration|September 7, 2021
Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulationInmaculada Sanjuan-Ruiz, Noé Govea-Perez, Melissa McAlonis-Downes, et al.
Acta Neuropathologica|March 1, 2017
Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosisJelena Scekic-Zahirovic, Hajer El Oussini, Sina Mersmann, et al.
Scientific Reports|November 10, 2023
Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic valueGabriele Nagel, Deborah Kurz, Raphael S Peter, et al.
Neurobiology of Disease|February 12, 2021
Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppressionJúlia Canet-Pons, Nesli-Ece Sen, Aleksandar Arsović, et al.
BMC Medicine|March 3, 2026
Disruption of the angiopoietin-like system connects lipid homeostasis and hypothalamic dysfunction in ALSSruthi Sankari Krishnamurthy, Adriana Zardini Buzatto, Caley Campkin, et al.
Plos One|June 21, 2012
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosisLuc Dupuis, Reinhard Dengler, Michael T Heneka, et al.
Neurobiology of Disease|June 8, 2013
Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with ageJudith Eschbach, Jérôme Sinniger, Jamal Bouitbir, et al.
Brain : a Journal of Neurology|March 18, 2016
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosisPauline Vercruysse, Jérôme Sinniger, Hajer El Oussini, et al.
Annals of Neurology|December 19, 2019
Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisAlbert C Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Human Molecular Genetics|March 1, 2013
Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosisEdor Kabashi, Hajer El Oussini, Valérie Bercier, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Molecular Neurodegeneration|September 7, 2021
Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulationInmaculada Sanjuan-Ruiz, Noé Govea-Perez, Melissa McAlonis-Downes, et al.
Acta Neuropathologica|March 1, 2017
Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosisJelena Scekic-Zahirovic, Hajer El Oussini, Sina Mersmann, et al.
Scientific Reports|November 10, 2023
Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic valueGabriele Nagel, Deborah Kurz, Raphael S Peter, et al.
Neurobiology of Disease|February 12, 2021
Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppressionJúlia Canet-Pons, Nesli-Ece Sen, Aleksandar Arsović, et al.
BMC Medicine|March 3, 2026
Disruption of the angiopoietin-like system connects lipid homeostasis and hypothalamic dysfunction in ALSSruthi Sankari Krishnamurthy, Adriana Zardini Buzatto, Caley Campkin, et al.
Plos One|June 21, 2012
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosisLuc Dupuis, Reinhard Dengler, Michael T Heneka, et al.
Neurobiology of Disease|June 8, 2013
Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with ageJudith Eschbach, Jérôme Sinniger, Jamal Bouitbir, et al.
Brain : a Journal of Neurology|March 18, 2016
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosisPauline Vercruysse, Jérôme Sinniger, Hajer El Oussini, et al.
Annals of Neurology|December 19, 2019
Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisAlbert C Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Human Molecular Genetics|March 1, 2013
Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosisEdor Kabashi, Hajer El Oussini, Valérie Bercier, et al.
Pageof 12